2021 Masterclass Series

Please note: Masterclass 1 has been postponed to 16-19 November 2021 due to COVID restrictions

The success of early-stage biopharma hinges not only on the efficacy and safety of a product, but on the company’s ability to achieve product-market-fit (PMF) and ultimately, attract investment. The path to PMF is contingent not only on the science behind a product, but on the art of achieving success in market.

Business and investment strategy is critical to success. Developing a robust strategy can be complex, expensive and time-consuming, and if not completed efficiently, can lead to costly delays, loss of investor confidence and even failure.

Advancing Global Business Strategy for BioPharma is a customised program designed to support early-stage biopharma executives. Participants will gain valuable skills and methodologies to develop effective business and investment strategies, optimise investor interest and accelerate their path to market. Two Masterclasses will be delivered in July and September:

Masterclass 1 | Creating a Value Story for Your Product | Commences 16 November 2021

Leading industry experts

Biointelect Pty Ltd is a strategic planning and commercialisation consultancy supporting early stage biotech to develop and drive strategy, identify and evaluate new business opportunities and find the right partners. Read more about Biointelect

Masterclass components

This Masterclass has three components (delivered in-person):

  • BioForum: 16 November | 4:00pm – 6:30pm | ACMI, Swinburne Studio, Federation Square, Melbourne
  • Masterclass Workshop: 17 November | 8:30am – 5:00pm | Cliftons Freshwater, Level 18, 2 Southbank Blvd, Southbank VIC 3006
  • 30-minute Advisory Session: Individual meetings held across 18 and 19 November (individual meeting times to be advised)

About this Masterclass

  • Take a deep dive into the fundamentals of value propositions and their critical impact on business and investment strategy development
  • Learn how value propositions are viewed by commercial partners vs investors and why this is important
  • Explore strategies and solution considerations for IP, Quality and Regulatory pathways
  • Become familiar with key considerations for reimbursement and health technology assessments and their impact on securing investment
  • Explore the nuances of business models and their impact on the product development story
  • Understand the value of Target Product Profiles and their practical uses when developing a clinical trial program
  • Gain valuable skills and tools to implement when engaging regulators and pitching to investors
  • Develop effective methodologies for creating pitch decks and attracting investment

Register here

Masterclass 2 | The Art of Capital Raising: Negotiating the Investment Landscape | Commences 14 September 2021

Leading industry experts

Gadens is a leading provider of legal services and recognised as a leading firm for advisory, transaction and disputes. They advise early stage companies through to large multinational pharmaceutical and medical device companies, as well as universities and research institutes. Read more about Gadens

The MRL Ventures Fund (MRLV) is the corporate venture arm of Merck & Co, Kenilworth, NJ and located in Cambridge, MA, USA. MRLV is a $250MM strategic corporate venture fund that invests globally in early-stage companies developing therapeutics for any indication using any modality. Read more about MRL Ventures Fund

Masterclass components

This Masterclass has three components (delivered in-person):

  • BioForum: 14 September | 4:00pm – 6:00pm | Gadens, Level 13, Collins Arch, 447 Collins Street, Melbourne
  • Masterclass: 15 September | 8:30am – 5:00pm | Sofitel Melbourne on Collins, West Tower Suite, 25 Collins Street, Melbourne
  • 30-minute advisory session: Individual meetings held on 16 or 17 September

About this Masterclass

  • Take a deep dive into the art of capital raising
  • Explore the global funding environment and learn critical factors for success when fundraising
  • Learn the nuances of Corporate Venture Capital vs. Venture Capital and the impact on early-stage biopharma
  • What’s in a VC pitch? Explore the art of the pitch, the VC diligence process and strategies to seal the deal
  • Become familiar with key legal considerations when raising capital and negotiating investment documents
  • Understand the nuances of capital: equity vs debt vs convertible note
  • Gain practical insights for getting the “house in order” to attract and facilitate investment
  • Learn key considerations and practical methodologies for negotiating terms sheets, shareholders’ agreements and subscription agreements
  • Become familiar with employee incentives and why they are important
  • Explore the different types of employee equity: ESOPs vs ESS vs LFSP, the advantages and disadvantages of each, and related tax considerations
  • Learn the importance of employment contracts and their impact on business
  • Gain practical insights on the importance of protecting intellectual property
  • Become familiar with key regulatory and market access issues
  • Gain practical skills and insights for effective tax structuring

Register here

BioBusiness Insights | 2021 Masterclass Series is kindly sponsored by the State Government of Victoria, Department of Jobs, Precincts and Regions.

Home

News & opinion

Member Directory

Events